BRINZOLAMIDE/BRIMONIDINE TARTRATE (SIMBRINZA) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

BRINZOLAMIDE/BRIMONIDINE TARTRATE

What is the Trade Name for BRINZOLAMIDE/BRIMONIDINE TARTRATE

SIMBRINZA

What is the Indication for BRINZOLAMIDE/BRIMONIDINE TARTRATE

  • 1 INDICATIONS AND USAGE SIMBRINZA (brinzolamide and brimonidine tartrate ophthalmic suspension) 1% and 0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. SIMBRINZA is a fixed combination of a carbonic anhydrase inhibitor and an alpha-2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]